07.08.24 -- Celiac Disease Drug Needs A Partner

Bioprocess Online is excited to introduce Bio-Expo Live, a series of live virtual events designed to empower biopharma professionals with the chance to conveniently explore the newest equipment and offerings in Upstream Bioprocessing, Downstream Bioprocessing and Bioprocess Quality, Data, and Analytical Solutions. Registration is free, reserve your spot today!

KSQ Therapeutics' CSO, Micah Benson, Ph.D., joins Cell & Gene: The Podcast host, Erin Harris, to discuss how Tumor-Infiltrating Lymphocytes (TILs) as a treatment modality have the potential to treat a variety of solid tumor types. Benson explains KSQ's Phase 1/2 clinical study, KSQ-001EX, which consists of TILs in which the SOCS1 gene is inactivated by CRISPR/Cas9 gene editing. Listen now and subscribe so you never miss an episode!

Learn about the contract BARDA awarded global vaccine maker CSL Seqirus to produce a stockpile of approximately 4.8 million vaccine doses in case of a bird flu pandemic.

Viral vectors are essential for delivering corrected genetic information to faulty genes within affected cells and are at the heart of the gene therapy process.

In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

How is current research driving the convergence of therapeutic modalities? What implications does this have for patients and healthcare? Find answers to these questions and more.